Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Monitoring ovarian function in oncology studies

Dr Elizabeth Trice Loggers - University of Washington, Seattle, USA
Monitoring ovarian function in oncology studies ( Dr Elizabeth Trice Loggers - University of Washington, Seattle, USA )
1 Jun 2024

Bortezomib and dexamethasone demonstrate efficacy benefit in key subgroups vs daratumumab, bortezomib, and dexamethasone in RRMM

Dr Maria-Victoria Mateos - University Hospital Salamanca, Salamanca, Spain
Bortezomib and dexamethasone demonstrate efficacy benefit in key subgroups vs daratumumab, bortezomib, and dexamethasone in RRMM ( Dr Maria-Victoria Mateos - University Hospital Salamanca, Salamanca, Spain )
1 Jun 2024

Safety and quality of life assessment, how do they impact patient decision? KCCure survey – part B

Prof Manuela Schmidinger and Dena Battle
Safety and quality of life assessment, how do they impact patient decision? KCCure survey – part B ( Prof Manuela Schmidinger and Dena Battle )
22 May 2024

HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive BC

Dr Guillermo Villacampa - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
HER2DX assay and survival outcomes: An individual-patient level meta-analysis of 2,031 patients with HER2-positive BC ( Dr Guillermo Villacampa  - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
21 May 2024

CAR-T, bispecifics or ADCs in late-stage RRMM

Dr Elena Zamagni - University of Bologna, Bologna, Italy
CAR-T, bispecifics or ADCs in late-stage RRMM ( Dr Elena Zamagni - University of Bologna, Bologna, Italy )
8 May 2024

Complementing clinical trials: Investigating the value of real world evidence with insights from TE NDMM

Dr Elena Zamagni - University of Bologna, Bologna, Italy
Complementing clinical trials: Investigating the value of real world evidence with insights from TE NDMM ( Dr Elena Zamagni - University of Bologna, Bologna, Italy )
8 May 2024

Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI

Dr Elena Zamagni - University of Bologna, Bologna, Italy
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI ( Dr Elena Zamagni - University of Bologna, Bologna, Italy )
8 May 2024

Treatment of multiple myeloma in Turkey

Dr Güldane Cengiz Seval - Ankara University, Ankara, Turkey
Treatment of multiple myeloma in Turkey ( Dr Güldane Cengiz Seval - Ankara University, Ankara, Turkey )
1 May 2024

Melflufen and dexamethasone versus pomalidomide and dexamethasone in relapsed refractory multiple myeloma

Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway
Melflufen and dexamethasone versus pomalidomide and dexamethasone in relapsed refractory multiple myeloma ( Dr Fredrik Schjesvold - Oslo Myeloma Center, Oslo, Norway )
30 Apr 2024

Grand Rounds: Improving quality of patient-centred care

Dr Didier Verhoeven, Prof Nirmala Bhoo Pathy and Dr Luzia Travado
Grand Rounds: Improving quality of patient-centred care ( Dr Didier Verhoeven, Prof Nirmala Bhoo Pathy and Dr Luzia Travado )
30 Apr 2024

Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer

Prof Jair Bar - Sheba Medical Center, Tel-Aviv, Israel
Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer ( Prof Jair Bar - Sheba Medical Center, Tel-Aviv, Israel )
29 Apr 2024

Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stage small cell lung cancer

Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece
Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stage small cell lung cancer ( Dr Giannis Mountzios - Henry Dunant Hospital Center, Athens, Greece )
26 Apr 2024